mean age at onset ± SD was 41.4 ± 18.1 (22-71) years. Mean disease duration to death in four patients was 5.5 ± 1.7 (3) (4) (5) (6) (7) years.
Two clinical patterns were evident: cognitive impairment with scarce neurological features or ataxia followed by cognitive impairment. Patients III-12 and IV-11 are reported in more details and are examples of the different clinical patterns.
Patient III-12 had onset at 38 years, complaining of lower limb dysesthesias, unsteadiness, falls and urinary urgency. The neurological examination, at the age of 40 years, showed ataxic gait, nystagmus in lateral gaze, jerky smooth pursuit, dysmetric saccades, hyponasal and slurred speech, dysphagia, marked dysmetria at heel-to-knee, absent knee and ankle jerks, decreased tone and Babinski signs. The patient was markedly depressed. The CT scan showed cerebellar atrophy, and VEP increased P1 latency. At the last examination, at the age of 43 years, she was unable to walk, hypotonic, and areflexic. Dementia, pseudobulbar affect, and urinary incontinence were present. She died of pneumonia at the age of 45 years.
Patient IV-11 (child of III-12) used to be a bright student. Onset was at about 22 years with decreased study performances and difficulties in the correct use of objects. When first observed, at the age of 25 years, she was disoriented in time and space and apraxic. Verbal fluency, memory and calculation were severely impaired. The neurological examination showed normal extraocular motility; brisk knee jerks; flexor plantar response; normal gait, coordination and vibration sense. Magnetic resonance imaging showed cerebral and cerebellar atrophy ( Figure 2 ); EEG showed diffuse slowing with spikes in left temporal leads; 99mTC-HMPAO SPET showed temporo-parietal decreased perfusion; neuropsychological examination marked deterioration of the cognitive functions. Neurophysiological evaluation showed increased P1 latency with normal amplitude and delayed central motor conduction time. At the last examination, at the age of 31 years, gait and stance were normal; she was unable to speak and completely dependent for feeding and personal hygiene. She also presented with insomnia, agitation and loss of weight.
Patient III-3 (file) started with ataxia at the age of 41 years, and received a diagnosis of multiple sclerosis. A pneumoencephalography showed enlargement of the third and fourth ventricles, pontine cisterns, and temporal horns of lateral ventricles. She died of aspiration pneumonia after six years.
Patient III-8 had an onset with frequent falls at the age of 71 years, and received a diagnosis of progressive supranuclear palsy. Ataxia followed and, in later stages, he was bedridden with severe dementia, muteness and aggressiveness. A CT scan performed in early stages of the disease showed cortical atrophy. He died at 77 of pneumonia.
Patient IV-3 (child of III-3) showed withdrawal behaviour, Dementia was subsequently diagnosed on the basis of memory disturbances, marked apraxia, and decreased speech output. Neuropsychological examination could not be performed. Magnetic resonance imaging showed cerebral and cerebellar atrophy; EEG spikes in the temporal leads. He died of pneumonia after a three-year disease duration. The postmortem examination was carried out several years ago. There were only histological slides of the cerebellar cortex stained with hematoxylin-eosin available. A decreased number of Purkinje cells and unicentric kuru-type eosinophilic plaques in the molecular layer were observed in absence of spongiform changes (Figure 3 ). No tissue for immunohistochemistry was available. Clinical files were not available for the other six patients. Deaths after a short lasting disabling disease were reported in all. Patients II-1, II-4, II-5 and II-6 were reported to be ataxic and to have died in their 30s or 40s.
Patients III-8 and IV-11 gave informed consent for molecular analysis. Sequencing of the PRNP open reading frame showed a T to C transition, resulting into a substitution of leucine for proline at residue 102 of the prion protein (P102L). 4 Patient III-8 was homozygous for methionine and IV-11 heterozygous for valine/methionine polymorphism on codon 129. Three Italian families have been reported to date. [4] [5] [6] All the families originated from Sicily and shared the same mutation (P102L). The patients from the present family are spread in different districts of Italy. Patient I-1 lived in northeastern Italy, but his family name is common in Sicily. A haplotype study on members of the four families may clarify if a founder-effect occurred. The phenotype varies from that characterized by ataxia and areflexia, followed by dementia, to that characterized by early cognitive impairment. The variable phenotype has already been reported 4 
